INS and Hypoglycemia: In a comprehensive review published in 2011, Little et al. evaluated a number of studies comparing NPH insulin and insulin detemir regarding the risk of hypoglycemia, with detemir administration exhibiting an ameliorating effect on the number of hypoglycemic episodes in the majority of studies in both T1DM and T2DM patients [59].